VASCUGEN
Vascugen is an induced pluripotent stem cell (iPSC) therapy company advancing its novel vasculogenic cell technology to develop and manufacture engineered vascular cells. Our vasculogenic cells have the potential to directly address ischemic disease conditions and to serve as a novel platform for delivery of therapeutic payloads in cardiovascular, solid tumor, and other indications. Vascugen’s research and development facility includes an integrated manufacturing facility for early-stage clinical manufacture of our products.
VASCUGEN
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.vascugen.com
Total Employee:
11+
Status:
Active
Total Funding:
10.84 M USD
Technology used in webpage:
Viewport Meta Google Font API Content Delivery Network LetsEncrypt SSL By Default HSTS Organization Schema Google Apps For Business Typekit LocalBusiness Schema
Similar Organizations
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Sojournix
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Current Employees Featured
Carter Cliff Founder & CEO @ Vascugen
Founder & CEO
2017-06-01
Teri F. Willey Independent Director @ Vascugen
Independent Director
2020-05-01
Mervin Yoder Scientific Founder @ Vascugen
Scientific Founder
Founder
Investors List
Indiana University Philanthropic Venture Fund
Indiana University Philanthropic Venture Fund investment in Pre Seed Round - Vascugen
Official Site Inspections
http://www.vascugen.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Vascugen"
Vascugen
Vascugen is an induced pluripotent stem cell (iPSC) therapy company advancing its novel vasculogenic cell technology to develop and manufacture engineered vascular cells.See details»
About Us - Vascugen
May 1, 2018 · Vascugen is dedicated to revolutionizing the standard of care for millions of patients suffering from severe conditions caused by restricted blood flow to tissues. Particularly for diabetic patients at high risk for limb amputation …See details»
Vascugen - The Org
Vascugen is an induced pluripotent stem cell (iPSC) therapy company advancing its novel vasculogenic cell technology to develop and manufacture engineered vascular cells.See details»
Vascugen - Crunchbase Company Profile & Funding
Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular diseases.See details»
Vascugen Company Profile 2024: Valuation, Funding
Vascugen General Information Description Developer of regenerative medicine therapies designed to directly address degenerative vascular and ischemic disease conditions.See details»
Vascugen - LinkedIn
Vascugen is a regenerative medicine company engaged in the development of advanced therapies to treat incurable conditions caused by loss or degeneration of blood vessels.See details»
David Mann - Chief Executive Officer at Vascugen | The Org
Currently, David is the Chief Executive Officer of Vascugen, a role they started in February 2023. Prior to this, they held the position of General Manager at Vascugen from 2018 to 2023. David …See details»
Matthew George - Assoc. Director R&D at Vascugen | The Org
Matthew George has worked at Vascugen since 2018. Matthew started as a Sr Scientist in June 2018 and then transitioned to the role of Assoc. Director R&D in June 2020. Prior to joining …See details»
Vascugen licenses stem cell tech for blood vessel regeneration ...
May 1, 2018 · INDIANAPOLIS – Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University School of Medicine related to blood …See details»
Technology — Vascugen
This technology is revolutionizing basic research and medicine with precise tools to edit gene sequences. We are integrating this expertise into our platform in order to broaden future applications of our iPSC-derived vasculogenic cell. …See details»
Vascugen licenses tech for blood vessel regen | EurekAlert!
May 1, 2018 · Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University School of Medicine related to blood vessel formation from …See details»
Vascugen - Contacts, Employees, Board Members, Advisors
Vascugen has 3 current employee profiles, including Founder & CEO Carter Cliff. Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular …See details»
Vascugen Licenses Stem Cell Technology for Blood Vessel …
INDIANAPOLIS, May 1, 2018 /PRNewswire/ -- Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of …See details»
Contact — Vascugen
5602 Research Park Blvd., Suite 213, Madison, WI 53719 . 2023 © Vascugen Inc. | Terms of Use | Privacy Policy | Career | Contact UsTerms of Use | Privacy Policy ...See details»
Vascugen - Funding, Financials, Valuation & Investors - Crunchbase
Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular diseases.See details»
Catherine Sazdanoff - Independent Director at Vascugen - The Org
In addition to their role at Strata Oncology, Catherine Sazdanoff is an Independent Director at Vascugen since August 2021. Catherine is also the CEO and President of Sazdanoff …See details»
Vascugen Company Profile - Office Locations, Competitors ... - Craft
Vascugen is a company specializing in regenerative medicine. It is engaged in the development of cell-based regenerative medicines and transformative therapies targeting vascular conditions …See details»
Harnessing Stem Cells for Blood Vessel Regeneration
May 16, 2018 · Vascugen recently announced that it had licensed stem cell technology for blood vessel regeneration at IU School of Medicine, which could lead to new treatment options for …See details»
Careers — Vascugen
Your Custom Text Here. About Us; Technology; Pipeline; Careers; Career OpportunitiesSee details»
Pipeline — Vascugen
Your Custom Text Here. About Us; Technology; Pipeline; Careers; PipelineSee details»